ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
Dow Jones
38,386.09
0.38%
US Dollar vs MXN
17.01015
-0.02%
Brent Oil
87.475
0.22%
Bitcoin
61,996.17
-2.88%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Alvontech (ALVO)

  7. Alvontech (ALVO) Noticias

ALVO Alvontech

14.22
0.00 (0.00%)
Pre Mercado
Última actualización: 03:05:25
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Alvontech ALVO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 14.22 03:05:25
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
14.22
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202403:00GLOBEU.S. Commercialization Agreement with Quallent to Drive..
24/4/202403:00GLOBEAlvotech Announces Topline Results from a Confirmatory..
19/4/202405:10GLOBEAlvotech signs U.S. agreement to expand access for newly..
16/4/202416:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202416:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
03/4/202406:41GLOBEAlvotech Hosts Audio Call for Investors at 8:15 am EDT on..
22/3/202415:15GLOBEAlvotech Announces Increase in Number of Own Shares
20/3/202415:15GLOBEAlvotech Reports Financial Results for Full Year 2023 and..
20/3/202406:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
05/3/202415:00GLOBEAlvotech Announces Webcast of Full Year 2023 Financial..
29/2/202415:05GLOBEAlvotech Appoints Interim Chief Quality Officer
26/2/202403:25GLOBEAlvotech Accepts Offer for the Sale of Shares for a value of..
23/2/202419:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
23/2/202419:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
15/2/202405:30GLOBEAlvotech Announces Expected Global Market Entry Dates for..
29/1/202403:00GLOBEAlvotech Announces Positive Top-Line Results from a..
19/1/202411:31DJNAlvotech Shares Climb After FDA Concludes Facility..
19/1/202410:30GLOBEAlvotech Provides Update on Status of Biologics License..
10/1/202402:30GLOBESTADA and Alvotech secure approval for Uzpruvo, Europe’s..
03/1/202402:30GLOBEAlvotech Clinical Study Results Demonstrate Therapeutic..
29/11/202303:00GLOBEAlvotech Announces Positive Top-Line Results from a..
28/11/202315:15GLOBEAlvotech Reports Financial Results for First Nine Months of..
21/11/202307:00GLOBEAlvotech to Report Financial Results for the First Nine..
14/11/202306:00GLOBEAlvotech and JAMP Pharma Announce Receipt of Marketing..
10/11/202308:30GLOBESTADA and Alvotech receive positive CHMP opinion for..
07/11/202307:00GLOBEAlvotech to Present at the Jefferies 2023 London Healthcare..
12/10/202303:00GLOBEAlvotech Provides Update on Status of U.S. Biologics License..
03/10/202307:29BWKashiv BioSciences Enters into Exclusive Licensing Agreement..
03/10/202304:00GLOBEAlvotech Enters into Exclusive Licensing Agreement with..
25/9/202303:00GLOBEAlvotech Announces Approval in Japan of AVT04 (ustekinumab),..
20/9/202303:30GLOBEAlvotech Provides U.S. Regulatory Update on AVT02, a..
05/9/202308:30GLOBEAlvotech Announces Changes to the Leadership Team
30/8/202315:15GLOBEAlvotech Reports Financial Results for First Six Months of..
29/8/202304:00GLOBEAlvotech and Bioventure Announce Approval of AVT02..
22/8/202308:15GLOBEAlvotech to Report Financial Results for the First Half of..
31/7/202303:00GLOBEAlvotech Completes $100 Million Convertible Bond Private..
24/7/202303:00GLOBETeva Pharmaceuticals and Alvotech Provide Update on..
03/7/202308:37DJNAlvotech Shares Rebound 20% After FDA Letter Selloff
28/6/202319:03DJNAlvotech Gets FDA Letter, Expects Delay in U.S. Approval of..
28/6/202318:00GLOBEAlvotech Provides Regulatory Update on Second Biologics..
12/6/202306:00BWAlvotech and Teva Secure U.S. License Date for AVT04, a..
12/6/202302:00GLOBEAlvotech and Teva Secure U.S. License Date for AVT04, a..
31/5/202304:20GLOBEAlvotech to Participate in Jefferies Healthcare Conference
24/5/202304:00GLOBEAlvotech and Advanz Pharma extend strategic partnership to..
19/5/202304:00GLOBEAlvotech Reports Financial Results for First three Months of..
17/5/202304:00GLOBEAlvotech to Participate in Morgan Stanley Annual..
15/5/202304:00GLOBEAlvotech Issues Annual Equality Report Covering 2022
10/5/202304:00GLOBEAlvotech enters into commercialization agreement with..
04/5/202304:00GLOBEAlvotech Initiates Confirmatory Patient Study for AVT05, a..
03/5/202308:00GLOBEAlvotech to Report First Quarter 2023 Financial Results and..

Su Consulta Reciente

NASDAQ
ALVO
Alvontech
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados